LIMN

Liminatus Pharma Inc-CL A Cross-source read$3.47 4.41%
Health CareCUSIP 53271X108· EOD Sep 11, 2026

Among active 13F managers last quarter, 1 opened and 3 reduced; the largest holder to move was Citadel Advisors LLC (−92%). No open-market insider trades in the last 180 days.

Tracked 13F holders
13
4 in Q2 2026 filings
13F value (tracked)
$61K
Smart-money readBearish
Net sellingNet buying
Funds · active managers, latest 13F
1 adding · 3 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean out and no leg opposes.

Price & smart-money activity

$3.47 4.41%5Y -99.3%
$3.19$362.37$721.55$1,081$1,4402021202220232025202623423
Hover for who · click for detailEnd-of-day closing prices52w $3.47 – $104.00

Who owns LIMN?

13 tracked 13F filers · ranked by shares held

13 tracked 13F filers disclose a position in LIMN as of the latest SEC 13F filings, a combined $61K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Geode Capital Management, LLC138K
$15K
+18%
Added · +21K sh
Q2 2026
2Jane Street Group, LLC71K
$12K
New
+71K sh
Q1 2026
3Citadel Advisors LLC56K
$6K
−92%
Reduced · −621K sh
Q2 2026
4UBS Group AG55K
$9K
+181%
Added · +35K sh
Q1 2026
5Vanguard Capital Management LLC50K
$6K
Held
Q2 2026
6StoneX Group Inc.26K
$4K
New
+26K sh
Q2 2026
7Vanguard Fiduciary Trust Co23K
$3K
Held
Q2 2026
8State Street Corp19K
$2K
Held
Q2 2026
9Vanguard Personalized Indexing Management, LLC13K
$1K
−62%
Reduced · −22K sh
Q2 2026
10Tower Research Capital LLC (TRC)8K
$1K
−15%
Reduced · −1K sh
Q1 2026
11Citigroup Inc7K
$1K
7k×
Added · +7K sh
Q1 2026
12BlackRock, Inc.313
$35
−98%
Reduced · −13K sh
Q2 2026
13Farther Finance Advisors, LLC14
$2
−55%
Reduced · −17 sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is LIMN being bought or sold by institutions?

Last quarter, 1 fund opened a new position in LIMN, while 3 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
1
fund took a first position
Reduced
3
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own LIMN also own

CompanyCo-held byTheir position there
Amazon.com IncAMZN4 funds$2.7B
Nvidia CorpNVDA4 funds$2.7B
Apple IncAAPL4 funds$2.5B
Microsoft CorpMSFT4 funds$1.6B
Alphabet Inc-CL AGOOGL4 funds$1.2B
Broadcom IncAVGO4 funds$1.2B
Eli Lilly & CoLLY4 funds$1.2B
BlackRock IncBLK4 funds$1.1B
Alphabet Inc-CL CGOOG4 funds$1.0B
Advanced Micro DevicesAMD4 funds$958.9M
Abbvie IncABBV4 funds$835.6M
Applied Materials IncAMAT4 funds$809.7M

Ranked by how many of LIMN's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in LIMN.

Insider activity (Form 4)

Full insider page →

No open-market insider transactions on file yet. Grants, gifts, and exercises live on the full insider page.

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
35
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
LIMN is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

4 tracked filers in Q2 2026 filingsstill filing
0713Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $23K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Share classes

Class13F holdersValue held
LIMNWSPAC Combination15 funds$62K
LIMNthis pageStock13 funds$61K

Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.

Recent filings

2 most recent

Keep exploring

Connected entities for LIMN

Browse more

Build

Ask your agent what changed in LIMN

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/LIMN/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for LIMN.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for LIMN. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.